Topic
stem cell research
198 published works
Microjuris Blog
Proponen legislación para obligar a planes médicos a cubrir terapias con células madre
El proyecto establece la obligación de que todo plan médico incluya como cubierta esencial aquellos tratamientos clínicos con células madre aprobados por la FDA
The IPKat
Patenting stem cell therapies in the US: The role and risks of product-by-process claims (Restem v Jadi cell)
Patenting stem cell therapies in the US is a difficult business, especially if your cell therapy product is defined solely by natural surface cell markers and lacks any form of…
The Faculty Lounge
Stem Cell Donation at . . . ESPN?
Yep. And it's a fascinating story. I’m told by the cricket lover in my house that Bavuma is a hero for other reasons, but it is his activism on stem…
The Patent Playbook
Federal Circuit Affirms Stem Cell Product-by-Process Claims: Lessons in Claim Construction and Inherency from <em>Restem LLV v. Jadi Cell LLC</em>
By Joseph Drayton, Erik Milch, Connor Villar
The Federal Circuit issued a precedential opinion on March 4, 2025, that serves as valuable guidance for product-by-process claims, particularly in the context of inherency in claim construction. In Restem,…
Regulatory Oversight
Arizona AG Takes Action Against Company for Alleged Deceptive Marketing Practices
By Troutman Pepper Locke State Attorneys General Team, Dascher Pasco
Earlier this month, Arizona Attorney General (AG) Kris Mayes announced a lawsuit alleging that CBR Systems, Inc. (CBR), one of the nation's largest cord blood banking companies, engaged in deceptive…
Drug & Device Law
Fat Cell Slurry is a Drug
United States v. Cal. STEM Cell Treatment Cntr., Inc., 2024 U.S. App. LEXIS 24525 (9th Cir. 2024), is not, strictly speaking, a product liability case at all. But it hits…
DC Medical Malpractice & Patient Safety Blog
FDA dithers dangerously on regulating sketchy ‘stem cell’ care and kid vaping
Yet more derelictions of duty by the federal Food and Drug Administration are happening now, in its handling of largely hokum treatments and health-threatening devices. The latest examples: drug safety regulators…
Mahany Law Blog
Hundreds of Unlicensed Stem Cell Clinics
By Brian Mahany
There Are Thousands of Unapproved Stem Cell Clinics in the U.S. At Best, You Are Throwing Away Your Money, at Worst, Your Life An investigation by the Arizona Republic found…
Mahany Law Blog
Invitrx Stem Cell Patients Beware – FDA Issues Stern Warning Letter
By Brian Mahany
Stem Cell Maker Invitrx Is in Trouble Again. Are Its Products Safe? You Be the Judge! We are one of the few law firms still handling stem cell lawsuits. The…
Domnick Cunningham & Whalen Blog
Unregulated Stem Cell Therapy Brings More Harm Than Help
By Ian Jack
In September 2019, the U.S. Food and Drug Administration (FDA) issued a warning to consumers: “Watch out for unapproved stem cell therapies!” The warning comes from the agency in response…